崧盛股份(301002.SZ):擬將募投項目結項 並將節餘募資永久補充流動資金
格隆匯9月30日丨崧盛股份(301002.SZ)公佈,公司於2024年9月30日召開第三屆董事會第十五次會議和第三屆監事會第十二次會議,分別審議通過了《關於募集資金投資項目結項並將節餘募集資金永久補充流動資金的議案》,同意公司對向不特定對象發行可轉換公司債券(以下簡稱“可轉債”)募集資金投資項目(以下簡稱“募投項目”)予以結項,並將節餘募集資金永久補充流動資金(具體實際金額以資金轉出當日專户餘額為準)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.